At Celgene, we take special care to provide patients safe access to our treatments. We have developed unique, industry-leading programs under which hundreds of thousands of patients worldwide have accessed the clinical benefits of our therapies.

Patient Safety At Celgene, we are focused on providing patients with safe access to our treatments. We subject our safety programs to independent external benchmarking that compares our activities to those of more than 15 other leading biopharmaceutical companies — and Celgene consistently places among the highest-performing companies. Learn More
Research & Development Celgene invests significant resources into the research and development of disease altering therapies for cancer and other serious immune-inflammatory conditions. Learn More	Innovation Impact Awards Through the Innovation Impact Award program, we seek to be a catalyst to help transform dialogue into game-changing, tangible action resulting in the incorporation of the patient voice at every step of the drug discovery and development continuum. Learn More
Celgene European Patient Group Support Across Europe, Celgene provides support to organizations and initiatives that make a positive impact on our patients, our communities and our world, today and for years to come. We are committed to improving the lives of patients and focus our support in areas where we can make the greatest impact. Learn More	EFPIA Spend Transparency Disclosure Celgene is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) and is compliant with Principles for Responsible Clinical Trial Data Sharing and is compliant with regulatory requirements for registration and results posting. Learn More